{"title":"ace抑制剂、钙拮抗剂和利尿剂是降压治疗的三大组成部分。固定三人组合的潜在优势","authors":"A. Konradi","doi":"10.18705/1607-419x-2023-29-2-231-240","DOIUrl":null,"url":null,"abstract":"The article describes the current situation in hypertension awareness and treatment, the role of treatment adherence and fixed-dose combinations in its improvement. The real world data form recent studies concerning adherence and outcome on the triple combination of amlodipine/indapamide/perindopril are demonstrated.","PeriodicalId":37695,"journal":{"name":"Arterial Hypertension (Russian Federation)","volume":"5 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ACE-inhibitor, calcium antagonist and diuretic as three major components of antihypertensive therapy. Potential advantages of fixed triple combinations\",\"authors\":\"A. Konradi\",\"doi\":\"10.18705/1607-419x-2023-29-2-231-240\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The article describes the current situation in hypertension awareness and treatment, the role of treatment adherence and fixed-dose combinations in its improvement. The real world data form recent studies concerning adherence and outcome on the triple combination of amlodipine/indapamide/perindopril are demonstrated.\",\"PeriodicalId\":37695,\"journal\":{\"name\":\"Arterial Hypertension (Russian Federation)\",\"volume\":\"5 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Arterial Hypertension (Russian Federation)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18705/1607-419x-2023-29-2-231-240\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arterial Hypertension (Russian Federation)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18705/1607-419x-2023-29-2-231-240","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
ACE-inhibitor, calcium antagonist and diuretic as three major components of antihypertensive therapy. Potential advantages of fixed triple combinations
The article describes the current situation in hypertension awareness and treatment, the role of treatment adherence and fixed-dose combinations in its improvement. The real world data form recent studies concerning adherence and outcome on the triple combination of amlodipine/indapamide/perindopril are demonstrated.
期刊介绍：
The main aims of the Journal include collecting and generalizing the knowledge in hypertensiology; education and professional development of cardiologists and medical doctors of other specialties, who deal with different issues regarding diagnostics, management and prevention of hypertension in both clinical practice and research. The Journal also calls attention to the most urgent and up-to-date questions in hypertensiology, cardiology and related sciences. There are additional objectives, such as increasing the availability, accessibility and recognition of Russian medical scientific achievements at the international level by improving the quality of the publication and the way they are presented; enabling the exchange of opinions and information between scientists and their wider communication. The main criteria for publication selection fit with the mentioned objectives and include currency, singularity, scientific and practical novelty, applied relevance etc.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
